Clinical trial
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or…
NCT00016172 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00016172 |
|---|---|
| Title | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma |
| Official title | A Phase I Study of ZD0473 and Doxil in Patients With Advanced Refractory Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | pegylated liposomal doxorubicin hydrochloride, picoplatin |
| Start date | Nov 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Jun 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: